Impact of intravenous tranexamic acid administration on reduction mammoplasty outcomes
Intravenous TXA use in reduction mammoplasty confers lower rates of postoperative wound complications, though its impact may be secondary to wound closure technique.
Authors
- Lauren O. Roussel
- Amy Maselli
- Stephanie Francalancia (ORCID: https://orcid.org/0000-0001-6713-8950)
- Margaret Wang (ORCID: https://orcid.org/0000-0001-5015-118X)
- Karl H. Breuing
- Damon McIntire
- Rachel Sullivan
- Kathryn Leeke
- Paul Liu
- Nikhil Sobti
- Mary Lou
- Daniel Kwan
Institutions
- Brown University (US)
Publication Details
- Journal
- JPRAS Open
- Published
- 2026-01-15
- DOI
- https://doi.org/10.1016/j.jpra.2026.01.002
- Primary Topic
- Blood transfusion and management
- Type
- article
- Field-Weighted Citation Impact
- 0.00